From: Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
DC quality parameter
Mean
Median
Range
CD14 (<25%)
4.33
0.2
(0, 29.5)
CD86 (>50%)
83.9
87.5
(60.7, 99.6)
CD11c (>50%)
97.1
99.0
(81.5, 99.6)
HLA-DR (>50%)
85.1
86.5
(71.9, 95.4)
Percent viability (>70%)
89.8
90.0
(78.9, 96.8)